Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Families and children news

Show

From To
UNAIDS, UNICEF and WHO urge countries in western and central Africa to step up the pace in the response to HIV for children and adolescents

At a high-level meeting in Dakar, Senegal, UNAIDS, the United Nations Children’s Fund (UNICEF) and the World Health Organization (WHO) urged countries in western and central Africa to do more to stop new HIV infections among children and adolescents and increase HIV testing and treatment coverage.

Published
17 January 2019
From
UNAIDS
Efavirenz in pregnancy is at least as safe as other antiretrovirals

An individual patient data analysis of almost 25,000 pregnancies in women living with HIV has found that the rate of birth defects following exposure to efavirenz was

Published
17 January 2019
By
Roger Pebody
UNAIDS, UNICEF and WHO urge countries in western and central Africa to step up the pace in the response to HIV for children and adolescents

At a high-level meeting in Dakar, Senegal, UNAIDS, the United Nations Children’s Fund (UNICEF) and the World Health Organization (WHO) urged countries in western and central Africa to do more to stop new HIV infections among children and adolescents and increase HIV testing and treatment coverage. 

Published
16 January 2019
From
UNAIDS press release
Study Explores Cost-Effectiveness of Conception Strategies for HIV Serodiscordant Couples

A new multi-institutional study has examined the cost-effectiveness of the pre-exposure prophylaxis (PrEP) combination of tenofovir disoproxil fumarate and emtricitabine (TDF/FTC) and assisted reproductive options for serodiscordant couples with an HIV-infected male and HIV-uninfected female looking to conceive. The study focused on examining scenarios in which ‘Undetectable=Untransmittable’ (’U=U’) infection, achieved with combination antiretroviral therapy, (cART) is not sufficient for conception.

Published
09 January 2019
From
Contagion Live
Efavirenz Likely Safe for Pregnant HIV-Positive Women

The prevalence of birth defects following use of efavirenz (EVF)-based antiretroviral therapy (ART) is not statistically different from non-EFV-based ART during conception or in the first trimester, researchers say.

Published
09 January 2019
From
Medscape (requires free registration)
Improved liver function, but progressive kidney damage, among children on antiretroviral therapy in Ethiopia

Among HIV-positive children with liver and kidney abnormalities, liver enzyme abnormalities improved while kidney function progressively deteriorated the longer the children were on antiretroviral therapy (ART). With the

Published
02 January 2019
By
Carole Leach-Lemens
Top 10 HIV Clinical Developments of 2018

It's the beginning of the end. Not in some apocalyptic way, but rather in how we think about the prevention and management of HIV.

Published
20 December 2018
From
The Body Pro
Women with HIV have increased risk of missed menstrual periods

Women living with HIV have a significantly higher risk of the menstrual disorder amenorrhea (missing three of more consecutive periods), according to a meta-analysis published in the online

Published
13 December 2018
By
Michael Carter
New BHIVA guidelines on HIV care in pregnancy and after birth

New British HIV Association (BHIVA) guidelines on the management of HIV in pregnancy have been issued this month, emphasising the continuing scientific uncertainty over HIV transmission through

Published
05 December 2018
By
Keith Alcorn
Digital health services highly effective in early infant diagnosis of HIV in Kenya

A digital health system combining online services with text messages is highly effective in early infant diagnosis of HIV according to findings from a cluster-randomised controlled trial in

Published
04 December 2018
By
Carole Leach-Lemens
← First12345...114Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.